Innovations In Clinical Neuroscience

MAR-APR 2017

A peer-reviewed, evidence-based journal for clinicians in the field of neuroscience

Issue link:

Contents of this Issue


Page 0 of 45

I N N O V A T I O N S C N S . C O M M A R C H – A P R I L 2 0 1 7 O F F I C I A L J O U R N A L O F Full Content Available on PubMed Central! A p e e r - r e v i e w e d j o u r n a l p r o v i d i n g e v i d e n c e - b a s e d i n f o r m a t i o n CLINICAL NEUROSCIENCE I n n o v a t i o n s i n I S C D D The International Society for CNS Drug Development ALSO INSIDE Original Research Interactive Voice Response and Text-based Self-report Versions of the Electronic Columbia-Suicide Severity Rating Scale Are Equivalent Review Liothyronine for Depression: A Review and Guidance for Safety Monitoring Original Research Neuroendocrine, Autonomic, and Metabolic Responses to an Orexin Antagonist, Suvorexant, in Psychiatric Patients with Insomnia Commentary Redefining Acute Relapses in Multiple Sclerosis: Implications for Phase 3 Clinical Trials and Treatment Algorithms Risk Management Managing Your Aging Patient Population V O L . 1 4 , N O . 3 – 4 Human Embryonic Stem Cells in the Treatment of Autism: A Case Series

Articles in this issue

Links on this page

Archives of this issue

view archives of Innovations In Clinical Neuroscience - MAR-APR 2017